Browse > Article

The Effect of Botulinum Toxin-A on the Survival of Random-Pattern Cutaneous Flap in Rat  

Kim, Young Seok (Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Yonsei University College of Medicine)
Lee, Chae Su (Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Yonsei University College of Medicine)
Yoo, Won Min (Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Yonsei University College of Medicine)
Tark, Kwan Chul (Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Yonsei University College of Medicine)
Publication Information
Archives of Plastic Surgery / v.35, no.4, 2008 , pp. 360-366 More about this Journal
Abstract
Purpose: Botulinum toxin type A(BoTA) can block the release of vasoconstriction cotransmitters as well as acetylcholine in nerve terminal. The authors observed that BoTA increases flap survival by preventing sympathetic collapse of peripheral vessels. Methods: 10 Sprague Dawley rats were divided into control(n=5), and BoTA group(n=5). $3{\times}10cm$ sized random pattern cutaneous flaps were elevated on the dorsal side in both groups. In BoTA group, BoTA was injected into the flap via intradermal to subdermal route, 7 days before the flap elevation. Flap survival rates (survival area/total area) were measured 7 days after the elevation. Cutaneous blood flow was measured in proximal, middle and distal compartments of the flap using laser Doppler flowmetry initially, preoperatively, at immediate postoperation, and 7 days after flap elevation, respectively. Histological examination was performed 7 days after the flap elevation. The number and shape of the vessels were evaluated under microscope. Results: Mean flap survival was $53.18{\pm}6.58%$ in control group and $93.79{\pm}6.06%$ in BoTA group, displaying statistically significant difference(p=0.0008, p<0.05). In the control group, blood flow to the middle and distal compartments of the flap decreased significantly immediately after flap elevation. In the BoTA group, blood flow to the middle compartment did not decrease(p=0.002) and slightly decreased in the distal compartment(p=0.001). Cutaneous blood flow was significantly higher in all compartments of the flap in BoTA group than in control group, 7 days after the flap elevation. In histopathologic examination, greater number of vessels were noted in the BoTA group than in the control group. Conclusion: Botulinum toxin A can increase the survival of the random pattern cutaneous flap in rats by preventing the sympathetic collapse of peripheral vessels.
Keywords
Botulinum toxin A; Random pattern cutaneous flap; Flap survival;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bhidayasiri R, Truong DD: Expanding use of botulinum toxin. J Neurol Sci 235: 1, 2005   DOI   ScienceOn
2 Rohrich RJ, Janis JE, Fagien S, Stuzin JM: The cosmetic use of botulinum toxin. Plast Reconstr Surg 112(5 Suppl): 177S, 2003   DOI   ScienceOn
3 Simpson LL: The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33: 155, 1981
4 Brin MF: Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 6: S146, 1997
5 Klein AW: The therapeutic potential of botulinum toxin. Dermatol Surg 30: 452, 2004   DOI   ScienceOn
6 Morris JL, Jobling P, Gibbins IL: Botulinum toxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons. Am J Physiol Heart Circ Physiol 283: H2627, 2002   DOI
7 Naumann M, Lowe NJ: Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomized, parallel group, double blind, placebo controlled trial. BMJ 323: 596, 2001   DOI   ScienceOn
8 Cordivari C, Misra VP, Catania S, Lees AJ: New therapeutic indications for botulinum toxins. Mov Disord 19(Suppl 8): S157, 2004   DOI   ScienceOn
9 Rizo J, S?dhof TC: Mechanics of membrane fusion. Nat Struct Biol 5: 839, 1998   DOI   ScienceOn
10 Huemer GM, Wechselberger G, Otto-Schoeller A, Gurunluoglu R, Piza-Katzer H, Schoeller T: Improved dorsal random-pattern skin flap survival in rats with a topically applied combination of nonivamide and nicoboxil. Plast Reconstr Surg 111: 1207, 2003   DOI   ScienceOn
11 Celik E, Tercan M, Uzunismail A, Saglam A: Versatility of botulinum toxin A: a use in stabilization of pedicled muscle flaps. Plast Reconstr Surg 117: 462, 2006   DOI   ScienceOn
12 Linderoth B, Gunasekera L, Meyerson BA: Effects of sympathectomy on skin and muscle microcirculation during dorsal column stimulation: animal studies. Neurosurgery 29: 874, 1991   DOI
13 Morris JL, Jobling P, Gibbins IL: Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 281: H2124, 2001   DOI
14 Banbury J, Siemionow M, Porvasnik S, Petras S, Zins JE: Muscle flaps' Triphasic microcirculatory response to sympathectomy and denervation. Plast Reconstr Surg 104: 730, 1999   DOI
15 Eleopra R, Tugnoli V, Quatrale R, Rossetto O, Montecucco C: Different types of botulinum toxin in humans. Mov Disord 19(Suppl 8): S53, 2004   DOI   ScienceOn